Intellectual Property News - Secerna LLP

The Edge Of Exclusivity From Revenue Cliff To Biosimilar Slope

The Edge of Exclusivity: From Revenue Cliff to Biosimilar Slope

News 05/05/2026

As we move through 2026 towards 2030, the pharmaceutical industry is no longer approaching the ‘super cliff’ but has already stepped off the edge and is part way down it.

Read more

Celebrating Chemistry Week 2024: Funding Schemes and Support Options

Industry news, News 07/11/2024

Celebrating Chemistry Week 2024: Funding Schemes and Support Options

JROBERTS - Secerna

Events, News 05/11/2024

Secerna to discuss IP at Manufacturing & Engineering North East (MENE)

Halloween IP

Industry news, News 29/10/2024

Halloween Patents: How IP Law Governs the Spookiest Holiday of the Year

T251018 – Exceptions To Patentability And Novelty Of Naturally Occurring Substances

Industry news, News 23/10/2024

T2510/18 – Exceptions to Patentability and Novelty of Naturally Occurring Substances

Copyright European Union. (1)

European, Industry news, News 22/10/2024

EU Council Approves Modernised Design Protection Package

AgriTech and Intellectual Property

Industry news, News 17/10/2024

AgriTech and Intellectual Property

Secerna Interior Shots September 2024 002

Industry news, News, Team news 08/10/2024

Secerna LLP Strengthens Chemistry & Pharmaceutical Team with New Patent Attorney

Mpox: Emerging Challenges and Pharmaceutical Innovations in the Face of a Global Health Crisis (Main)

Industry news, News 07/10/2024

Mpox: Emerging Challenges and Pharmaceutical Innovations in the Face of a Global Health Crisis

Navigating Employee Inventor Rights

Industry news, News 30/09/2024

Navigating Employee Inventor Rights

14 15 16 17 18 19 20 21 22 23 24